Associated Papers
Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism.
Isvoran A et al.
Drug Discovery Today, 2022
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy.
Rendo V et al.
Nature Communications, 2020
32161261 (PubMed )
Supplement: 41467_2020_15111_MOESM1_ESM.pdf
The molecular basis for the broad substrate specificity of human sulfotransferase 1A1.
Berger I et al.
Plos One, 2011
Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.
Ginsberg G et al.
Critical Reviews in Toxicology, 2010
Genetic diversity and function in the human cytosolic sulfotransferases.
Hildebrandt MA et al.
The Pharmacogenomics Journal, 2007
Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3.
Barnett AC et al.
The Journal of Biological Chemistry, 2004
Select a paper to view details